CSL Behring Commitment

For more than 100 years, CSL Behring has specialized in plasma therapies to improve the quality of life in patients with bleeding disorders, immune deficiencies, inherited emphysema, and other conditions.

CSL Behring offers many programs and services to the bleeding disorders community, in addition to its range of blood products. Some of these include:

Sponsoring programs and activities that benefit people with bleeding disorders
Working with government authorities to help make sure patients have access to care
Improving and expanding educational and outreach efforts
Funding medical research

Featured programs and services of the CSL Behring Commitment include:

CSL Behring Foundation for Research and Advancement of Patient Health

This is the only nonprofit foundation dedicated exclusively to charitable, scientific, and educational endeavors that benefit the bleeding disorders community. The Foundation provides grants for research projects and community initiatives that advance the standard of care for people with bleeding disorders. More>>

Gettin’ in the Game^SM

Gettin’ in the Game^SM was started by CSL Behring to encourage kids with bleeding disorders to be physically active. Children and their families can get sports tips from professional athletes, participate in exercises or sports competitions, and meet other kids with bleeding disorders. More>>

Gettin’ in the Game^SM Junior National Championship

The JNC is a fun-filled annual golf and baseball competition for children ages 7 through 18. More>>

Reimbursement Resource Center

Call 1-800-676-4266 for expert advice and information about insurance matters, including health insurance reimbursement for CSL Behring products. More>>

Patient Assistance Program

This program provides medically necessary therapies to qualified patients who are uninsured, underinsured, or who cannot afford their prescribed therapy. More>>

Project Red Flag (PRF)

Project Red Flag (PRF) is a campaign by the National Hemophilia Foundation aimed at educating women and their healthcare providers about the symptoms, diagnosis, and treatment of bleeding disorders. CSL Behring proudly supports PRF, along with the Centers for Disease Control and Prevention. More >>

VWD Consumer Advisory Committee

CSL Behring hosts meetings with VWD patients and parents to keep current on the needs and interests of the VWD community, and to provide a forum for consumers to exchange ideas.

For more information about any of the programs and services offered by CSL Behring, call our Consumer Affairs Center at 1-888-508-6978.

Important Safety Information

Stimate^® Nasal Spray is contraindicated in individuals with a known hypersensitivity to desmopressin or any of the components of Stimate^®. Stimate^® should not be used in patients with type 2B VWD, since platelet aggregation may be induced. Stimate^® Nasal Spray is for intranasal use only.

To decrease the potential for hyponatremia or water intoxication, especially in the young and the elderly, patients using desmopressin who are not in need of antidiuretic hormone for its antidiuretic effect should be cautioned to reduce fluid intake, ingesting only enough to satisfy thirst. Such patients should be monitored for the rare occurrence of an extreme decrease in plasma osmolality that could result in seizures, possibly leading to coma.

Other adverse reactions reported with use of injectable and/or intranasal desmopressin acetate include headache, nausea, somnolence, dizziness, chest pain, palpitations and tachycardia, and severe allergic reactions, including anaphylaxis. See full prescribing information for a complete list of adverse reactions.